Aniridia-absent patella syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:1069OMIM:106220Q87.8
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Aniridia-absent patella syndrome, also known as aniridia-patellar aplasia syndrome, is an extremely rare genetic disorder characterized by the combination of aniridia (absence or severe underdevelopment of the iris of the eye) and absent or hypoplastic patellae (kneecaps). This condition affects both the ocular and musculoskeletal systems. The eye abnormalities can lead to significant visual impairment, photosensitivity, and may be associated with other ocular complications such as glaucoma, cataracts, corneal changes, and foveal hypoplasia. The absence or underdevelopment of the patella can affect knee joint stability and mobility. This syndrome has been reported in only a very small number of families in the medical literature, making it one of the rarest conditions involving aniridia. It is considered distinct from other aniridia-associated syndromes such as WAGR syndrome and from nail-patella syndrome, which also involves patellar abnormalities but has different associated features. The condition appears to follow an autosomal dominant inheritance pattern based on reported familial cases. There is no specific cure for aniridia-absent patella syndrome. Management is supportive and multidisciplinary, involving ophthalmologists for monitoring and treating eye complications (including glaucoma management, use of tinted lenses for photosensitivity, and surgical interventions when needed) and orthopedic specialists for addressing knee joint instability or functional limitations related to patellar aplasia. Regular ophthalmologic surveillance is essential to detect and manage progressive eye complications early.

Clinical phenotype terms— hover any for plain English:

AniridiaHP:0000526Aplasia/Hypoplasia of the patellaHP:0006498
Inheritance

Autosomal dominant

Passed on from just one parent; each child has about a 50% chance of inheriting it

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Aniridia-absent patella syndrome.

View clinical trials →

No actively recruiting trials found for Aniridia-absent patella syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Aniridia-absent patella syndrome community →

No specialists are currently listed for Aniridia-absent patella syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Aniridia-absent patella syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Aniridia-absent patella syndromeForum →

No community posts yet. Be the first to share your experience with Aniridia-absent patella syndrome.

Start the conversation →

Latest news about Aniridia-absent patella syndrome

No recent news articles for Aniridia-absent patella syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Aniridia-absent patella syndrome

What is Aniridia-absent patella syndrome?

Aniridia-absent patella syndrome, also known as aniridia-patellar aplasia syndrome, is an extremely rare genetic disorder characterized by the combination of aniridia (absence or severe underdevelopment of the iris of the eye) and absent or hypoplastic patellae (kneecaps). This condition affects both the ocular and musculoskeletal systems. The eye abnormalities can lead to significant visual impairment, photosensitivity, and may be associated with other ocular complications such as glaucoma, cataracts, corneal changes, and foveal hypoplasia. The absence or underdevelopment of the patella can a

How is Aniridia-absent patella syndrome inherited?

Aniridia-absent patella syndrome follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Aniridia-absent patella syndrome typically begin?

Typical onset of Aniridia-absent patella syndrome is neonatal. Age of onset can vary across affected individuals.